Idexx Laboratories Investing Cash Flow decreased by 19.2% to -$33.54M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.3%, from -$29.61M to -$33.54M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -17.4% CAGR.
Typically negative for growing companies as they reinvest cash; a positive value suggests the company is liquidating assets faster than it is buying them.
The aggregate sum of all cash inflows and outflows related to a company's long-term investments and capital assets. It s...
Mature companies with high cash flow often show large negative values here as they recycle profits into new growth or financial instruments.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$174.66M | -$49.68M | -$44.04M | -$41.84M | -$55.09M | -$49.20M | -$49.23M | -$39.51M | -$27.47M | -$27.84M | -$30.44M | -$106.94M | -$32.91M | -$27.37M | -$39.84M | -$29.61M | -$33.63M | -$44.87M | -$28.13M | -$33.54M |
| QoQ Change | — | +71.6% | +11.3% | +5.0% | -31.7% | +10.7% | -0.1% | +19.7% | +30.5% | -1.3% | -9.3% | -251.4% | +69.2% | +16.8% | -45.6% | +25.7% | -13.6% | -33.4% | +37.3% | -19.2% |
| YoY Change | — | — | — | — | +68.5% | +1.0% | -11.8% | +5.6% | +50.1% | +43.4% | +38.2% | -170.7% | -19.8% | +1.7% | -30.9% | +72.3% | -2.2% | -64.0% | +29.4% | -13.3% |